Review Article Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.33696/Gynaecology.2.020

Postmenopausal Hyperhidrosis and Vasomotor Symptoms in Menopause Should be Treated Differently – A Narrative Review

  • 1Department of Medical Sciences, Dermatology and Venereology, Uppsala University, Uppsala, Sweden
  • 2Svettmottagningen (the Sweat Clinic), Stockholm, Sweden
  • 3Department of Neurology, Uppsala University Hospital, Sweden
  • 4Medical Officer eSanté, Sweden
+ Affiliations - Affiliations

Corresponding Author

Carl Swartling, carl.swartling@svettmottagningen.se

Received Date: July 14, 2021

Accepted Date: August 26, 2021


Postmenopausal hyperhidrosis (PMH) is an important differential diagnosis to vasomotor symptoms (VMS) in menopause. The objective is to describe the differences in clinical presentation and treatment of the two conditions.

Patients suffering from PMH represent a unique cohort of patients with primary hyperhidrosis and should therefore not be treated in the same way as those displaying VMS during menopause. Postmenopausal hyperhidrosis is a neglected differential diagnosis to the common VMS in menopause. The two diagnoses have similarities but also distinct differences in presentation. However, the treatments of the diagnoses differ substantially. This review explains the differences in clinical presentation and treatments and suggests botulinum toxin type B in the treatment of vasomotor symptoms due to anti-oestrogen therapy.

Author Information X